Elizabeth Faust
Director/Board Member at BIOMEA FUSION, INC.
Net worth: - $ as of 2024-03-30
Elizabeth Faust active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIOMEA FUSION, INC. | Director/Board Member | 2022-05-31 | - |
| Independent Dir/Board Member | 2022-05-31 | - |
Career history of Elizabeth Faust
Former positions of Elizabeth Faust
| Companies | Position | Start | End |
|---|---|---|---|
| TRICIDA, INC. | Chief Tech/Sci/R&D Officer | 2019-12-02 | 2020-07-31 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 2016-02-23 | - |
| Corporate Officer/Principal | 2016-02-23 | 2018-05-31 | |
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | 2013-02-28 | 2015-10-31 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Chief Tech/Sci/R&D Officer | 2009-08-26 | 2010-04-30 |
| Corporate Officer/Principal | 2008-04-30 | 2009-08-26 | |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Training of Elizabeth Faust
| University of California, Los Angeles | Doctorate Degree |
| Auburn University | Undergraduate Degree |
| University of California, Riverside | Graduate Degree |
Statistics
International
| United States | 10 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| TRICIDA, INC. | Health Technology |
| BIOMEA FUSION, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Elizabeth Faust
- Experience
